| Issue Date |
Title |
Author(s) |
| 2014 |
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia |
Huang, Xinfang;Du, Hui;Gu, Jieruo;Zhao, Dongbao;Jiang, Lindi;Li, Xinfu;Zuo, Xiaoxia;Liu, Yi;Li, Zhanguo;Li, Xiangpei;Zhu, Ping;Li, Juan;Zhang, Zhiyi;Huang, Anbin;Zhang, Yuanchao;Bao, Chunde |
| Jun-2020 |
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial |
Su, Jinmei;Li, Mengtao;He, Lan;Zhao, Dongbao;Wan, Weiguo;Liu, Yi;Xu, Jianhua;Xu, Jian;Liu, Huaxiang;Jiang, Lindi;Wu, Huaxiang;Zuo, Xiaoxia;Huang, Cibo;Liu, Xiumei;Li, Fen;Zhang, Zhiyi;Liu, Xiangyuan;Dong, Lingli;Li, Tianwang;Chen, Haiying;Li, Jingyang;He, Dongyi;Lu, Xin;Huang, Anbin;Tao, Yi;Wang, Yanyan;Zhang, Zhuoli;Wei, Wei;Li, Xiaofeng;Zeng, Xiaofeng |
| 2019 |
Efficacy and Safety of Loxoprofen Hydrogel TransdermalPatch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial |
Zhao, Dongbao;Chen, Zhiwei;Hu, Shaoxian;Lin, Jianhao;Shao, Zengwu;Wang, Guochun;Xiao, Weiguo;Zheng, Yi;Zhang, Zhiyi;Shi, Yeqing;Li, Zhanguo |
| 2015 |
Feasibility and Influential Factors in Performing Self-Evaluation of DAS28 with Smart System of Disease Management (SSDM) By RA Patient in China |
Rong, Mu;Xiao, Fei;Li, Chun;Guan, Jianlong;Shen, Yan;Zhao, Dongbao;Xu, Xia;Jiang, Lindi;Chen, Huiyong;Su, Li;Jia, Yuhua;Zhang, Li;Liu, Yuan;Li, Zhan-Guo |
| 2013 |
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23 |
Li, Yongzhe;Zhang, Kunlin;Chen, Hua;Sun, Fei;Xu, Juanjuan;Wu, Ziyan;Li, Ping;Zhang, Liuyan;Du, Yang;Luan, Haixia;Li, Xi;Wu, Lijun;Li, Hongbin;Wu, Huaxiang;Li, Xiangpei;Li, Xiaomei;Zhang, Xiao;Gong, Lu;Dai, Lie;Sun, Lingyun;Zuo, Xiaoxia;Xu, Jianhua;Gong, Huiping;Li, Zhijun;Tong, Shengquan;Wu, Min;Li, Xiaofeng;Xiao, Weiguo;Wang, Guochun;Zhu, Ping;Shen, Min;Liu, Shengyun;Zhao, Dongbao;Liu, Wei;Wang, Yi;Huang, Cibo;Jiang, Quan;Liu, Guijian;Liu, Bin;Hu, Shaoxian;Zhang, Wen;Zhang, Zhuoli;You, Xin;Li, Mengtao;Hao, |
| 2018 |
Pattern Shift and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China |
Mu, Rong;Li, Chun;Yang, Jing;Wei, Hua;Huang, Jianlin;Fan, Wenqiang;Wang, Yongfu;Wang, Hongzhi;Zou, Jinmei;Shi, Xiaofei;Xin, Xiafei;Wu, Jianhong;Li, Fen;Li, Shouxin;Yang, Huiqin;Zhang, Anbing;Zhao, Dongbao;He, Jinchang;Zhang, Junli;Li, Luo;Ji, Peng;Rong, Xiaofeng;Jiang, Fong;Wang, Ling;Jia, Yuhua;Xiao, Fei;Li, Zhan-Guo |
| 2013 |
Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus |
Zhang, Xuewu;Zhang, Fengchun;Wu, Donghai;Bao, Chunde;Zhu, Ping;Zhang, Xiao;Huang, Cibo;He, DongYi;Tao, Yi;Fang, Yongfei;Gu, Jieruo;Wu, Huaxiang;Sun, Lingyun;Yang, Xiuyan;Huang, Feng;Xu, Huji;Zhao, Dongbao;Zhang, Miaojia;Zheng, Yi;Li, Zhanguo |
